Stock report · Delisted · Nasdaq
Third Harmonic Bio Inc. (THRD)
5.38USD Delisted Final close · Jul 30, 2025
THRD no longer trades. Third Harmonic Bio was delisted from the Nasdaq in July 2025.
All prices on this page are historical. The last trade was on July 30, 2025, at $5.38.
THRD stock price history
Final trading statistics
- Final close
- $5.38
- Final trading day
- Jul 30, 2025
- Market cap at delisting
- $242.79M
- Shares outstanding
- 45.13M
- Final 52-week range
- $3.18 – $16.02
- Avg. volume (final 3 mo.)
- 278,497
- All-time high
- $23.97 · Oct 2022
- All-time low
- $3.25 · Feb 2025
- Return since IPO
- -68.4%
- Beta
- 2.13
- Book value / share
- $6.06
- Price / book
- 0.89
About Third Harmonic Bio Inc.
Third Harmonic Bio, Inc. was a biopharmaceutical company developing medicines for inflammatory diseases of the skin, airways and digestive tract. It worked on oral small molecules that block KIT, a cell surface receptor that controls mast cell function and survival, including THB335 for mast cell-driven inflammatory, respiratory and gastrointestinal conditions. It held a license agreement with Novartis Pharma AG. Known as Project IGE, Inc. until June 2019, it was incorporated in 2019 and based in San Francisco. Its stock was delisted from the Nasdaq in July 2025, with the last trade on July 30, 2025 at $5.38.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- San Francisco, CA
- Employees
- 31
- IPO date
- September 14, 2022
- Delisted
- July 30, 2025
- SEC CIK
- 1923840
Third Harmonic Bio financials before the delisting
The last 5 fiscal years Third Harmonic Bio reported as a public company, fiscal year ending December.
THRD revenue and net income
THRD earnings per share
THRD annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $0.00 | $45.5M | −$1.09 |
| FY2023 | $0.00 | −$30.8M | −$0.98 |
| FY2022 | $0.00 | −$37.7M | −$1.22 |
| FY2021 | $0.00 | −$29.6M | — |
| FY2020 | $0.00 | −$12.8M | — |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
Third Harmonic Bio stock FAQ
What happened to Third Harmonic Bio stock?
Third Harmonic Bio was delisted from the Nasdaq in July 2025. The final close was $5.38 on July 30, 2025.
Can I still buy THRD stock?
No. THRD is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on July 30, 2025.
What was the last price of THRD?
THRD last closed at $5.38 on July 30, 2025, which valued the company at about $242.79M.
How did Third Harmonic Bio do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, Third Harmonic Bio reported revenue of $0.00 and net income of $45.5M.
When did Third Harmonic Bio go public?
Third Harmonic Bio shares started trading on September 14, 2022.
THRD no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.